Theolytics raises $6.8 million Series A round co-led by Epidarex Capital and Taiho Ventures to advance viral cancer therapies

Theolytics awarded Innovate UK boost to help combat Ovarian Cancer

Theolytics Announces Appointment of Immatics’ Carsten Reinhardt to its Board of Directors

Theolytics announced winners of the Santander Pitch Finale

Charlotte Casebourne named one of 30 Rising Leaders In the Life Sciences 2020

Margaret Duffy named one of the 50 Movers & Shakers in BioBusiness 2019

BioCentury ‘Emerging from stealth, UK-based Theolytics is ...'